AU2003234895A1 - Veterinary antiparasite suspension injection - Google Patents

Veterinary antiparasite suspension injection

Info

Publication number
AU2003234895A1
AU2003234895A1 AU2003234895A AU2003234895A AU2003234895A1 AU 2003234895 A1 AU2003234895 A1 AU 2003234895A1 AU 2003234895 A AU2003234895 A AU 2003234895A AU 2003234895 A AU2003234895 A AU 2003234895A AU 2003234895 A1 AU2003234895 A1 AU 2003234895A1
Authority
AU
Australia
Prior art keywords
antiparasite
veterinary
suspension injection
suspension
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003234895A
Inventor
Xiaoxi Dai
Zhende Pan
Yuwan Wang
Yan Xue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CNA031045855A external-priority patent/CN1500492A/en
Priority claimed from CNA031045847A external-priority patent/CN1522704A/en
Application filed by Individual filed Critical Individual
Publication of AU2003234895A1 publication Critical patent/AU2003234895A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003234895A 2002-11-18 2003-05-26 Veterinary antiparasite suspension injection Abandoned AU2003234895A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CN02148804.5 2002-11-18
CN02148804 2002-11-18
CN03104585.5 2003-02-19
CNA031045855A CN1500492A (en) 2002-11-18 2003-02-19 Veterinary antiparasite suspension injection
CN03104584.7 2003-02-19
CNA031045847A CN1522704A (en) 2003-02-19 2003-02-19 Parasite resistant slow release injection formulation for animals
PCT/CN2003/000390 WO2004045581A1 (en) 2002-11-18 2003-05-26 Veterinary antiparasite suspension injection

Publications (1)

Publication Number Publication Date
AU2003234895A1 true AU2003234895A1 (en) 2004-06-15

Family

ID=32329399

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003234895A Abandoned AU2003234895A1 (en) 2002-11-18 2003-05-26 Veterinary antiparasite suspension injection

Country Status (2)

Country Link
AU (1) AU2003234895A1 (en)
WO (1) WO2004045581A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102333968B (en) * 2009-02-27 2016-05-04 Ntn株式会社 Rolling bearing
AU2013257335B2 (en) * 2012-05-01 2017-03-02 Nexan Corporation Limited Anthelmintic compositions
CN107349236B (en) * 2017-07-24 2020-10-23 佛山市南海东方澳龙制药有限公司 Doramectin preparation and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
DE69229318T2 (en) * 1991-09-30 1999-11-18 Merck & Co Inc Hydrogenated castor oil-containing injectable formulations with extended drug delivery
ATE249206T1 (en) * 1997-12-03 2003-09-15 Merck & Co Inc LONG-ACTING, INJECTABLE FORMULATIONS CONTAINING CASCIN OIL
CN1241404A (en) * 1999-07-16 2000-01-19 王玉万 Avermectin-or ivermectin-containing slow releasing injecta
CN1375287A (en) * 2001-03-16 2002-10-23 王玉万 Veterinary mixed suspension injection containing chlorocyaniosaliamine or its sodium salt

Also Published As

Publication number Publication date
WO2004045581A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
AU2003201850A1 (en) N-alkylsulfonyl-substituted amide derivatives
AU2003225031A1 (en) Eptfe-reinforced perfluoroelastomers
AU2003262634A1 (en) Partition mount with extended-length head
IL163749A0 (en) Novel florfenicol-type antibiotics
AUPS032202A0 (en) Teether
AU2003301309A1 (en) Munitions trailer
AU2003260787A1 (en) Protein kinases
AU2003208719A1 (en) Chassis dynanometer
AU2003260148A1 (en) Aquarium
AU2003278389A1 (en) Gel feed
AU2003205259A1 (en) Process for finish-abrading optical-fiber-connector end-surface
AUPS034702A0 (en) Trailer
AU2003231370A1 (en) Amide derivatives
AU2003234895A1 (en) Veterinary antiparasite suspension injection
AU2003235889A1 (en) Amide derivatives
AU2003299043A1 (en) Unloading assembly
AU2003202694A1 (en) Torero protein
AU2003278718A1 (en) Stars-a muscle-specification-binding protein
AU2003270055A1 (en) Neurotransmission-associated proteins
AU2002360025A1 (en) Famotidine injection
AU2003232176A1 (en) Protein c variants with altered properties
EP1504541B8 (en) Rake-demodulator with multicode-finger
AU2003300785A1 (en) Carbohydrate-associated proteins
AU2003254865A1 (en) Akt2-BINDING PROTEIN
AU2003251456A1 (en) N-bisaryl- and n-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase